CAS 804518-63-6

2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl

CAS: 804518-63-6

Fórmula: C₂₄H₃₃N₅O₄S

Pureza: 99%

Forma y color: Solid

Peso molecular: 487.6149

Ref: IN-DA00GAHY

Yonkenafil

CAS: 804518-63-6

Fórmula: C₂₄H₃₃N₅O₄S

Forma y color: Pale Yellow Solid

Peso molecular: 487.62

Ref: 4Z-Y-001001

Yonkenafil-d8

CAS: 804518-63-6

Fórmula: C₂₄H₂₅D₈N₅O₄S

Forma y color: Pale Yellow Solid

Peso molecular: 495.67

Ref: 4Z-Y-001002

2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

CAS: 804518-63-6

2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

Pureza: 98%

Peso molecular: 487.63g/mol

Ref: 54-OR1063705

Yonkenafil-d7

CAS: 804518-63-6

Fórmula: C₂₄H₂₆D₇N₅O₄S

Forma y color: Pale Yellow Solid

Peso molecular: 494.66

Ref: 4Z-Y-001003

Yonkenafil

Producto controlado

CAS: 804518-63-6

Fórmula: C₂₄H₃₃N₅O₄S

Forma y color: Neat

Peso molecular: 487.615

Ref: TR-Y100810

Yonkenafil

CAS: 804518-63-6

Yonkenafil is a potent, selective inhibitor of the enzyme cGMP-specific phosphodiesterase type 5 (PDE5). It is used for the treatment of erectile dysfunction. Yonkenafil has been shown to inhibit nitric oxide synthase (NOS) activity, which may be responsible for its neuroprotective effect. This compound also inhibits microglia activation and neuronal death in vitro and in vivo. Yonkenafil has been shown to be effective in the treatment of Parkinson's disease symptoms, such as cognitive impairment and motor deficits.

Fórmula: C₂₄H₃₃N₅O₄S

Pureza: Min. 95%

Peso molecular: 487.6 g/mol

Ref: 3D-EHB51863

Yonkenafil

CAS: 804518-63-6

Yonkenafil, a PDE5 inhibitor, may reduce stroke damage and aid in Alzheimer's treatment.

Fórmula: C₂₄H₃₃N₅O₄S

Forma y color: Solid

Peso molecular: 487.61

Ref: TM-T68665